FDA Clearance Tracker · P180027
Flow Re-Direction Endoluminal Device (FRED®) System
Last checked: Nov 20, 2026Latest source record: Dec 16, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Dec 16, 2019
Approved
Time to decision
502 days
Received Aug 1, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P180027
- Device name
- Flow Re-Direction Endoluminal Device (FRED®) System
- Applicant
- MicroVention, Inc.
- Applicant location
- Aliso Viejo, CA
- Received
- Aug 1, 2018
- Decided
- Dec 16, 2019
- Decision
- Approved
- Supplements
- 13 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Intracranial aneurysm flow diverter (OUT)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for The Flow Re-Direction Endoluminal Device (FRED®) System. The Flow Re-Direction Endoluminal Device (FRED®) System is indicated for use in the internal carotid artery from the petrous segment to the terminus for the endovascular treatment of adult patients (22 years of age or older) with wide-necked (neck width >= 4 mm or dome-to-neck ratio < 2) saccular or fusiform intracranial aneurysms arising from a parent vessel with a diameter >= 2.0 mm and <= 5.0 mm.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OUT. The earliest in FDA's data is P100018, decided Apr 6, 2011.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for MicroVention, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254035 · Decided Sep 3, 2026 · 261 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
K261808 · Decided Jun 30, 2026 · 29 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K261549 · Decided Jun 9, 2026 · 29 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.